Shareholder Information
Share management and Shareholder Meeting information
Investors
Results, Reports and Presentations
-
July 2025 Investor Presentation
July 31 2025 Download (1.70MB) -
Indivior Q2 2025 Financial Results
July 31 2025 Download (392KB) -
Indivior Q1 2025 Financial Results
April 24 2025 Download (153KB) -
Annual Report and Accounts 2024
March 17 2025 Download (7.25MB) -
Indivior FY and Q4 2024 Financial Results
February 20 2025 Download (589KB)
Latest News
-
Indivior Reports Second Quarter 2025 Financial Results and Raises FY 2025 Financial Guidance
July 31 2025 -
Indivior Announces Completion of Cancellation of Secondary Listing on London Stock Exchange; Primary Listing on Nasdaq to be Maintained
July 25 2025 -
Indivior Real World Evidence Study Finds Medications for Opioid Use Disorder, Particularly Extended-Release Buprenorphine, Reduced Odds of Emergency Department Visits for Patients with Opioid Use Disorder
July 23 2025 -
Indivior Appoints Vanessa Procter as Executive Vice President of Corporate Affairs
July 8 2025 -
Indivior Announces Inclusion in the U.S. Russell 2000® and 3000® Indexes
June 30 2025
.png)
.png)